BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 29917250)

  • 21. The landscape of m6A regulators in esophageal cancer: molecular characteristics, immuno-oncology features, and clinical relevance.
    Li Z; Zheng C; Huang L; Yin X; Wang Z; Liu C; Li B
    Ann Transl Med; 2022 Dec; 10(24):1347. PubMed ID: 36660671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma.
    Ibuki Y; Nishiyama Y; Tsutani Y; Emi M; Hamai Y; Okada M; Tahara H
    PLoS One; 2020; 15(4):e0231116. PubMed ID: 32251457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in Esophageal Cancer Mortality and Stage at Diagnosis by Race and Ethnicity in the United States.
    Corona E; Yang L; Esrailian E; Ghassemi KA; Conklin JL; May FP
    Cancer Causes Control; 2021 Aug; 32(8):883-894. PubMed ID: 34003396
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF
    Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The management of localized esophageal squamous cell carcinoma: Western approach.
    Zaidi N; Kelly RJ
    Chin Clin Oncol; 2017 Oct; 6(5):46. PubMed ID: 29129086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
    Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
    Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of oncogenes in esophageal squamous cell carcinoma and their therapeutic potentials.
    Xiao S; Huang G; Zeng W; Zhou J; Li Y; Fan T; Liu X; Xia J; Zeng X
    Clin Transl Oncol; 2023 Mar; 25(3):578-591. PubMed ID: 36315334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.
    Sasaki Y; Tamura M; Koyama R; Nakagaki T; Adachi Y; Tokino T
    World J Gastroenterol; 2016 Feb; 22(7):2284-93. PubMed ID: 26900290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA in the pathogenesis and prognosis of esophageal cancer.
    Gu J; Wang Y; Wu X
    Curr Pharm Des; 2013; 19(7):1292-300. PubMed ID: 23092349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ESOMIR: a curated database of biomarker genes and miRNAs associated with esophageal cancer.
    Sindhoo A; Sipy S; Khan A; Selvaraj G; Alshammari A; Casida ME; Wei DQ
    Database (Oxford); 2023 Oct; 2023():. PubMed ID: 37815872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Approach to Localized Squamous Cell Cancer of the Esophagus.
    Weidenbaum C; Gibson MK
    Curr Treat Options Oncol; 2022 Oct; 23(10):1370-1387. PubMed ID: 36042147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumoral Expression of CD166 in Human Esophageal Squamous Cell Carcinoma: Implications for Cancer Progression and Prognosis.
    Zhang X; Yuan A; Zhao X; Li Z; Cui G
    Cancer Biother Radiopharm; 2020 Apr; 35(3):214-222. PubMed ID: 32196367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies.
    Testa U; Castelli G; Pelosi E
    Curr Oncol; 2023 Jan; 30(1):610-640. PubMed ID: 36661697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma.
    Chen FF; Zhang SR; Peng H; Chen YZ; Cui XB
    Mol Med Rep; 2019 Oct; 20(4):3649-3660. PubMed ID: 31485619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival-associated alternative splicing signatures in esophageal carcinoma.
    Mao S; Li Y; Lu Z; Che Y; Sun S; Huang J; Lei Y; Wang X; Liu C; Zheng S; Zang R; Li N; Li J; Sun N; He J
    Carcinogenesis; 2019 Mar; 40(1):121-130. PubMed ID: 30304323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA and mRNA integration network reconstruction reveals novel key regulators in esophageal squamous-cell carcinoma.
    Alaei S; Sadeghi B; Najafi A; Masoudi-Nejad A
    Genomics; 2019 Jan; 111(1):76-89. PubMed ID: 29317304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target.
    Ma S; Paiboonrungruan C; Yan T; Williams KP; Major MB; Chen XL
    Ann N Y Acad Sci; 2018 Dec; 1434(1):164-172. PubMed ID: 29752726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling.
    Sudo K; Kato K; Matsuzaki J; Boku N; Abe S; Saito Y; Daiko H; Takizawa S; Aoki Y; Sakamoto H; Niida S; Takeshita F; Fukuda T; Ochiya T
    JAMA Netw Open; 2019 May; 2(5):e194573. PubMed ID: 31125107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
    Wang WT; Guo CQ; Cui GH; Zhao S
    World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current advances in esophageal cancer proteomics.
    Uemura N; Kondo T
    Biochim Biophys Acta; 2015 Jun; 1854(6):687-95. PubMed ID: 25233958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.